Inicio › Cáncer de seno › Vermont
Ensayos clínicos de Cáncer de seno en Vermont
6 estudios sobre Cáncer de seno buscan participantes en Vermont.
Ciudades en Vermont
Texto oficial del estudio (inglés)
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- The University of Vermont Medical Center Inc., Burlington
ReclutandoFase 2
Edades de 18 en adelante · Mujeres · Actualizado el 22 sept 2026 · NCT07287098A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- The University of Vermont Medical Center Inc., Burlington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07174336A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- University of Vermont Medical Center, Burlington
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT06492616Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
ReclutandoFase 3
Edades de 18 a 60 · Mujeres · Actualizado el 2 sept 2026 · NCT05879926De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
- Dartmouth Cancer Center - North, Saint Johnsbury
ReclutandoFase 3
Edades de 50 a 70 · Todos los sexos · Actualizado el 23 abr 2026 · NCT04852887Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Central Vermont Medical Center, Berlin Corners
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 mar 2026 · NCT06418204De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.